What is the most recent earnings date for MRNA stock?
MODERNA INC (MRNA) last reported earnings on 2/13/2026.
MODERNA INC (MRNA) Earnings History & Surprises
NASDAQ:MRNA • US60770K1079
Current stock price
52.56 USD
-0.83 (-1.55%)
At close:
52.5265 USD
-0.03 (-0.06%)
After Hours:
MRNA Earnings overview
Past quarterly earnings results for MODERNA INC (MRNA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$2.12
- Revenue Estimate
- 232.19M
Last Reported
Most Recent- Release Date
- Feb 13, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$2.11
- EPS Surprise
- 21.71%
- Revenue Surprise
- 6.17%
Beat Rate
Last 8 Quarters 88%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -2.11 | -2.70 | 21.71% | 27.49% | 678M | 638.62M | 6.17% | -29.81% |
| Q3 2025 | -0.51 | -2.15 | 76.27% | -1,800.00% | 1.016B | 904.27M | 12.36% | -45.44% |
| Q2 2025 | -2.13 | -3.03 | 29.60% | 36.04% | 142M | 115.2M | 23.26% | -41.08% |
| Q1 2025 | -2.52 | -3.20 | 21.22% | 17.92% | 108M | 108.32M | -0.30% | -35.33% |
| Q4 2024 | -2.91 | -2.74 | -6.26% | -629.09% | 966M | 961.7M | 0.45% | -65.64% |
| Q3 2024 | 0.03 | -1.95 | 101.54% | 100.31% | 1.862B | 1.275B | 46.04% | 1.69% |
| Q2 2024 | -3.33 | -3.45 | 3.51% | 8.01% | 241M | 134.83M | 78.74% | -29.94% |
| Q1 2024 | -3.07 | -3.66 | 16.04% | -1,715.79% | 167M | 99.451M | 67.92% | -91.03% |
| Q4 2023 | 0.55 | -0.99 | 155.49% | -84.76% | 2.811B | 2.545B | 10.45% | -44.71% |
| Q3 2023 | -9.53 | -1.97 | -384.77% | -476.68% | 1.831B | 1.432B | 27.86% | -45.57% |
| Q2 2023 | -3.62 | -4.12 | 12.15% | -169.08% | 344M | 326.03M | 5.51% | -92.76% |
| Q1 2023 | 0.19 | -1.81 | 110.52% | -97.79% | 1.862B | 1.202B | 54.91% | -69.30% |
| Q4 2022 | 3.61 | 4.77 | -24.31% | -68.02% | 5.084B | 5.118B | -0.66% | -29.50% |
| Q3 2022 | 2.53 | 3.36 | -24.66% | -67.14% | 3.364B | 3.597B | -6.48% | -32.30% |
| Q2 2022 | 5.24 | 4.64 | 12.94% | -18.89% | 4.749B | 4.147B | 14.52% | 9.07% |
| Q1 2022 | 8.58 | 5.32 | 61.43% | 202.11% | 6.066B | 4.709B | 28.82% | 213.16% |
| Q4 2021 | 11.29 | 10.10 | 11.80% | 1,736.23% | 7.211B | 6.928B | 4.08% | 1,163.54% |
| Q3 2021 | 7.70 | 9.23 | -16.58% | 1,405.08% | 4.969B | 6.331B | -21.51% | 3,046.93% |
| Q2 2021 | 6.46 | 6.07 | 6.35% | 2,183.87% | 4.354B | 4.292B | 1.44% | 6,457.23% |
| Q1 2021 | 2.84 | 2.43 | 16.66% | 911.43% | 1.937B | 2.078B | -6.79% | 22,959.52% |
| Q4 2020 | -0.69 | -0.35 | -95.61% | - | 570.7M | 285M | 100.25% | - |
| Q3 2020 | -0.59 | -0.43 | -35.84% | - | 157.9M | 79.063M | 99.71% | - |
| Q2 2020 | -0.31 | -0.36 | 13.37% | - | 66.4M | 27.977M | 137.34% | - |
| Q1 2020 | -0.35 | -0.36 | 2.79% | - | 8.4M | 17.432M | -51.81% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
37.20%
Max EPS beat (4)
76.27%
Min EPS beat (4)
21.22%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
10.37%
Max Revenue beat (4)
23.26%
Min Revenue beat (4)
-0.30%
Analysis
In the last 4 quarters, MRNA has consistently beaten EPS estimates in all releases
MRNA has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, MRNA has beaten the EPS estimates by 37.2% on average.
In the last 4 quarters, MRNA has beaten the revenue estimates by 10.4% on average.
Related analysis
MODERNA INC / MRNA Earnings FAQ
Did MRNA stock beat earnings estimates in the most recent quarter?
MODERNA INC (MRNA) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does MODERNA INC (MRNA) beat earnings estimates?
In the last 4 quarters, MODERNA INC (MRNA) has beaten EPS estimates in 4 out of 4 releases.